News

Below you'll find the ALLG's 2016 news announcements.

 
Australian Blood Cancer Researchers Make New Discoveries Dec 2016
Clinician members of the ALLG have achieved international recognition at the American Society of Haematology Annual Meeting for breakthrough research results in the treatment of blood cancers, including leukaemia, lymphoma and myeloma. more ...
 
ALLG Survey on Selected Activities 2016 | Summary of the Results Nov 2016
The ALLG distributed a survey related to selected ALLG Activities (in particular its promotional activities and training program specific to clinical trial design) to the ALLG Membership in late June 2016. The feedback was sought to assist the ALLG in providing the relevant information to enhance its conduct of clinical trials and thus the outcomes for the participants. more ...
 
October Scientific Meeting Highlights Oct 2016
The ALLG held its biannual Scientific Meeting in Sydney in October. This was a very exciting meeting to be at. The participants discussed several new trials which are due to commence soon that offer novel treatment options to improve outcomes for patients with blood cancers. more ...
 
World-first New Standard of Care for Early Stage Lymphoma Patients Sep 2016
In a world-first breakthrough for early stage low-grade lymphoma, set to change the management of the disease worldwide, an international clinical trial has found that patients live longer without a relapse with immuno-chemotherapy plus radiotherapy treatment rather than radiotherapy alone. more ...
 
Medical Research Future Fund (MRFF) Aug 2016
As part of the 2014–15 Budget, the Australian Government announced the establishment of the $20 billion Medical Research Future Fund (MRFF) as a dedicated vehicle for investment in medical research. Here are some highlights from the ALLG submission to both the strategy and priorities consultations. more ...
 
ALLG HD08 'RATHL' Study Published July 2016
We have demonstrated recent success with an international collaboration, and produced results that will enliven treatment and outcomes for patients with Hodgkin Lymphoma. Congratulations to Leanne Berkahn and Judith Trotman on the publication of the ALLG HD08 study in the New England Journal of Medicine (NEJM). more ...
 
"Cancer Recovery" – Art Display Jun 2016
To mark the 2016 International Clinical trials Day, ALLG held a special event on 20 May featuring the artwork of Professor Ary Hoffmann. This was a perfect opportunity for the ALLG to link between blood cancer — patient journey and the ongoing need for research. more ...
 
May Scientific Meeting Highlights May 2016
The ALLG May 2016 Scientific Meeting held in Adelaide was a great success. The guest speaker, Prof Bruce Robinson AM, Chair of the NHMRC Research Council addressed the topic of the NHMRC and research in the future. more ...
 
Scientific Advisory Committee (SAC) Changes Apr 2016
Thank you to Campbell Tiley and Welcome Will Stevenson. more ...
 
Professor Tim Hughes – A CML Odyssey Mar 2016
Tim Hughes gave the de Gruchy Oration at the HAA Annual Scientific Meeting in Adelaide last year. He looked back at his time in CML clinical research. more ...
 
ALLG Looking to the Future Feb 2016
The ALLG strategic plan adopted by the Board will direct our work over the next five years. more ...
 
NHL21 – Oral Presentation at ASH Jan 2016
An ALLG study in lymphoma generated significant interest at the most prestigious international conference in the field of blood cancers. The American Society of Haematology (ASH) in December heard Prof Hertzberg present the first official results of the ALLG NHL21 study. more ...